Status:
COMPLETED
Is Myocardial Stunning Induced by Continuous Renal Replacement Therapy a Reality in Critically Ill Patients?
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Acute Kidney Injury KDIGO 3
Continuous Renal Replacement Therapy Initiated by the Clinician in Charge Without Emergency
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Myocardial stunning during chronic intermittent hemodialysis is a well-described phenomenon. Little case series of patients presenting myocardial stunning during renal replacement therapy for acute ki...
Eligibility Criteria
Inclusion
- Age \> 18 years old
- Acute Kidney Injury grade 3 (KDIGO)
- Indication for renal replacement therapy for the clinician in charge
Exclusion
- Emergency indication to renal replacement therapy (pH\<7.15, Kaliemia \> 6mmol/L, refractory pulmonary oedema)
- Poor echogenicity with speckle tracking analysis failure
- Chronic hemodialysis
- Extra corporeal membrane oxygenation, left ventricular assist device.
Key Trial Info
Start Date :
April 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 18 2025
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT05209230
Start Date
April 15 2022
End Date
December 18 2025
Last Update
January 8 2026
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Département d'anesthésie-réanimation Hôpital cardiologique Louis Pradel Groupe Hospitalier Est
Bron, Bron, France, 69500
2
Ruste Martin
Bron, BRON, France, 69500
3
Hopital Edourd Herriot
Lyon, France, 69008